KR920009387A - 약물 경피투여용 제제 - Google Patents
약물 경피투여용 제제 Download PDFInfo
- Publication number
- KR920009387A KR920009387A KR1019910021715A KR910021715A KR920009387A KR 920009387 A KR920009387 A KR 920009387A KR 1019910021715 A KR1019910021715 A KR 1019910021715A KR 910021715 A KR910021715 A KR 910021715A KR 920009387 A KR920009387 A KR 920009387A
- Authority
- KR
- South Korea
- Prior art keywords
- pressure
- meth
- acrylic acid
- sensitive
- local anesthetic
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title claims 4
- 239000003814 drug Substances 0.000 title claims 4
- 238000002360 preparation method Methods 0.000 title claims 3
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims 4
- 239000010410 layer Substances 0.000 claims 4
- 239000003589 local anesthetic agent Substances 0.000 claims 4
- 238000009472 formulation Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 2
- 229940035674 anesthetics Drugs 0.000 claims 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 claims 2
- 239000003193 general anesthetic agent Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 claims 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 239000003522 acrylic cement Substances 0.000 claims 1
- 125000005907 alkyl ester group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 230000003444 anaesthetic effect Effects 0.000 claims 1
- 229960003150 bupivacaine Drugs 0.000 claims 1
- 229960002023 chloroprocaine Drugs 0.000 claims 1
- VDANGULDQQJODZ-UHFFFAOYSA-N chloroprocaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 claims 1
- 229960001747 cinchocaine Drugs 0.000 claims 1
- PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 claims 1
- 229960003920 cocaine Drugs 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 229960004194 lidocaine Drugs 0.000 claims 1
- 229960002409 mepivacaine Drugs 0.000 claims 1
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 claims 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 238000006116 polymerization reaction Methods 0.000 claims 1
- 229960001807 prilocaine Drugs 0.000 claims 1
- MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 claims 1
- 229960004919 procaine Drugs 0.000 claims 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229960002372 tetracaine Drugs 0.000 claims 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (6)
- 유연성 있는 지지층 및 국소 마취제를 40내지 65중량%의 비로 함유하고, 그 속에 용해된 국소 마취제의 양(As)에 대한 용해되지 않은 국소 마취제의 양(Ac)의 비, Ac/As 가 0.1 내지 1.8인 감압성(prssure-sensitive) 점착제층을 포함함을 특징으로 하는 약물 경피투여용 제제.
- 제1항에 있어서, 국소 마취제를 아미드 마취제 및 에스테르 마취제로 이루어진 군으로 부터 하나 이상 선택함을 특징으로 하는 약물 경피투여용 제제.
- 제1항에 있어서, 국소 마취제를 코카인, 프로카인, 클로로프로카인, 테트라카인, 리도카인, 메피바카인, 프릴로카인, 부피바카인, 디부카인 및 약제학적으로 허용되는 이의 염으로 이루어진 군으로 부터 하나 이상 선택함을 특징으로 하는 약물 경피투여용 제제.
- 제1항에 있어서, 감압성 접착제층이 감압성 아크릴 점착제의 층임을 특징으로 하는 경피투여용 제제.
- 제4항에 있어서, 감압성 아크릴 점착제가 (메트) 아크릴산 알킬 에스테르 및 (메트) 아크릴산의 공중합체임을 특징으로 하는 약물 경피투여용 제제.
- 제4항에 있어서, 감압성 아크릴 점착제가 (메트) 아크릴산 알킬 에스테르 65 내지 99중량% 및 (메트) 아크릴산 1 내지 35중량%의 중합 반응에 의해 수득됨을 특징으로 하는 약물 경피투여용 제제.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2338885A JP2849950B2 (ja) | 1990-11-30 | 1990-11-30 | 経皮吸収製剤 |
JP90-338885 | 1990-11-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR920009387A true KR920009387A (ko) | 1992-06-25 |
KR0185715B1 KR0185715B1 (ko) | 1999-05-01 |
Family
ID=18322294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019910021715A KR0185715B1 (ko) | 1990-11-30 | 1991-11-29 | 약물 경피투여용 제제 |
Country Status (10)
Country | Link |
---|---|
US (1) | US5368860A (ko) |
EP (1) | EP0488137B1 (ko) |
JP (1) | JP2849950B2 (ko) |
KR (1) | KR0185715B1 (ko) |
AT (1) | ATE120642T1 (ko) |
CA (1) | CA2056653C (ko) |
DE (1) | DE69108683T2 (ko) |
DK (1) | DK0488137T3 (ko) |
ES (1) | ES2070401T3 (ko) |
TW (1) | TW198692B (ko) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993020138A2 (en) * | 1992-03-30 | 1993-10-14 | Alza Corporation | Polymer system containing a partially soluble compound |
DE69517816T2 (de) | 1994-09-14 | 2000-12-28 | Minnesota Mining & Mfg | Matrix für transdermale wirkstofffreisetzung |
US5573778A (en) * | 1995-03-17 | 1996-11-12 | Adhesives Research, Inc. | Drug flux enhancer-tolerant pressure sensitive adhesive composition |
DE19524691A1 (de) * | 1995-07-06 | 1997-01-09 | Liedtke Pharmed Gmbh | Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen |
US5667799A (en) * | 1995-10-30 | 1997-09-16 | Caldwell; Larry J. | Method for treating headache pain with topical local anesthetic compositions |
DE19546159A1 (de) * | 1995-12-11 | 1997-06-12 | Liedtke Pharmed Gmbh | Methode und Zusammensetzung einer topisch wirksamen Therapie postoperativer und posttraumatischer Wundschmerzen |
US6365178B1 (en) * | 1996-09-06 | 2002-04-02 | Watson Pharmaceuticals, Inc. | Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions |
US5985317A (en) * | 1996-09-06 | 1999-11-16 | Theratech, Inc. | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents |
US6103771A (en) * | 1998-03-20 | 2000-08-15 | Caldwell Galer Incorporated | Method of treating neuroma pain |
CA2343100A1 (en) * | 1998-09-08 | 2000-05-04 | Srinivasan Venkateshwaran | Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs |
WO2001064149A1 (en) * | 2000-02-29 | 2001-09-07 | Jie Zhang | Improved transdermal drug patch |
WO2005107834A1 (en) | 2004-04-30 | 2005-11-17 | Clawson Burrell E | Apparatus and methods for isolating human body areas for localized cooling |
US7666914B2 (en) * | 2004-06-03 | 2010-02-23 | Richlin David M | Topical preparation and method for transdermal delivery and localization of therapeutic agents |
US20060079558A1 (en) * | 2004-09-27 | 2006-04-13 | Bridge Pharma. Inc. | R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics |
US7718674B2 (en) * | 2004-09-27 | 2010-05-18 | Bridge Pharma, Inc. | Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine |
JP2006248996A (ja) * | 2005-03-10 | 2006-09-21 | Nitto Denko Corp | 経皮吸収型貼付剤 |
CA2655809C (en) * | 2006-07-21 | 2013-10-01 | Bridge Pharma, Inc. | Dermal anesthetic compounds |
US8337883B2 (en) | 2006-11-03 | 2012-12-25 | Durect Corporation | Transdermal delivery systems |
CA2738524C (en) | 2008-10-02 | 2013-11-26 | Mylan Inc. | Method for making a multilayer adhesive laminate |
KR101080380B1 (ko) | 2009-08-14 | 2011-11-04 | 한국수력원자력 주식회사 | 접착력이 향상된 수화겔 접착용 필름 및 이의 제조방법 |
KR101955175B1 (ko) * | 2010-04-13 | 2019-03-06 | 나지브 바불 | 1-메틸-2'-6'-피페콜옥실리디드의 피부 약제학적 조성물 및 사용 방법 |
AU2016259348B9 (en) * | 2010-04-13 | 2018-11-29 | Relmada Therapeutics, Inc. | Dermal pharmaceutical compositions of 1-Methyl-2',6' pipecoloxylidide and method of use |
DE102011100619A1 (de) | 2010-05-05 | 2012-01-05 | Amw Gmbh | Transdermales therapeutisches System (TTS) mit einem Gehalt an einem Opiod-Analgetikum |
KR20170055487A (ko) * | 2014-10-02 | 2017-05-19 | 닛토덴코 가부시키가이샤 | 경피 투여용 백신 의약 조성물 |
CN109316469B (zh) * | 2018-10-09 | 2022-02-22 | 北京德默高科医药技术有限公司 | 一种稳定的高载药利多卡因透皮贴剂及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58148815A (ja) * | 1982-02-26 | 1983-09-05 | Nitto Electric Ind Co Ltd | 複合医薬製剤の製法 |
GB2156215B (en) * | 1984-03-05 | 1988-03-02 | Nitto Electric Ind Co | Percutaneous absorption type adhesive pharmaceutical preparation |
US4655768A (en) * | 1984-07-06 | 1987-04-07 | Avery International Corporation | Bandage for sustained delivery of drugs |
US4764381A (en) * | 1985-12-06 | 1988-08-16 | Key Pharmaceuticals, Inc. | Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol |
EP0331392A3 (en) * | 1988-03-01 | 1990-02-14 | Alza Corporation | Anesthesia and antisepsis of the skin |
WO1989011872A1 (en) * | 1988-06-09 | 1989-12-14 | Alza Corporation | Permeation enhancer comprising ethanol and glycerol monooleate |
US5120325A (en) * | 1991-06-12 | 1992-06-09 | Fleshtones Products Co., Inc. | Color-matched sterile adhesive bandages containing melanin-like pigment composition |
-
1990
- 1990-11-30 JP JP2338885A patent/JP2849950B2/ja not_active Expired - Lifetime
-
1991
- 1991-11-19 TW TW080109062A patent/TW198692B/zh not_active IP Right Cessation
- 1991-11-26 AT AT91120100T patent/ATE120642T1/de not_active IP Right Cessation
- 1991-11-26 DK DK91120100.2T patent/DK0488137T3/da active
- 1991-11-26 ES ES91120100T patent/ES2070401T3/es not_active Expired - Lifetime
- 1991-11-26 DE DE69108683T patent/DE69108683T2/de not_active Expired - Lifetime
- 1991-11-26 US US07/798,149 patent/US5368860A/en not_active Expired - Lifetime
- 1991-11-26 EP EP91120100A patent/EP0488137B1/en not_active Expired - Lifetime
- 1991-11-29 KR KR1019910021715A patent/KR0185715B1/ko not_active IP Right Cessation
- 1991-11-29 CA CA002056653A patent/CA2056653C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5368860A (en) | 1994-11-29 |
TW198692B (ko) | 1993-01-21 |
JP2849950B2 (ja) | 1999-01-27 |
EP0488137B1 (en) | 1995-04-05 |
ES2070401T3 (es) | 1995-06-01 |
DE69108683D1 (de) | 1995-05-11 |
JPH04208229A (ja) | 1992-07-29 |
CA2056653A1 (en) | 1992-05-31 |
ATE120642T1 (de) | 1995-04-15 |
KR0185715B1 (ko) | 1999-05-01 |
DK0488137T3 (da) | 1995-08-28 |
DE69108683T2 (de) | 1995-10-05 |
EP0488137A3 (en) | 1993-02-03 |
EP0488137A2 (en) | 1992-06-03 |
CA2056653C (en) | 2000-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920009387A (ko) | 약물 경피투여용 제제 | |
CA1118350A (en) | Local anesthetic mixture for topical application, process for its preparation, as well as method for obtaining local anesthesia | |
KR950031058A (ko) | 경피 흡수 제제 | |
BR9909948A (pt) | Formulação anestésica tópica | |
KR920021140A (ko) | 약학 조성물 | |
KR950007850A (ko) | 항균물질 및 항궤양물질 포함 제제 | |
JPS5775918A (en) | Anti-inflammaboty and analgesic plaster | |
KR930007444A (ko) | 4-비페닐아세트 산(bpaa)를 함유하는 제약학적 조성물 | |
BR0109150A (pt) | Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente | |
CA2299950A1 (en) | Oral adhesive sheet and oral adhesive preparation | |
JP2006520801A5 (ko) | ||
KR910018019A (ko) | 니트로글리세린의 경피 투여형 약제 | |
KR890015732A (ko) | 소염성 겔 | |
KR900009084A (ko) | 1-이소부틸-1H-이미다조[4,5-c] 퀴놀린-4-아민을 함유하는 국소제제 및 경피 투여시스템 | |
KR927003531A (ko) | 국부 마취 및 진통 효과를 갖는 치환 4-페닐-4-피페리딘카르복스아미드 및 그의 제조 방법 | |
PT1063983E (pt) | Sistema terapeutico transdermico (tts) contendo oxibutinina | |
KR900003105A (ko) | N-2,3-부타디엔일 트리- 및 테트라아미노알칸 유도체 | |
KR950003262A (ko) | 1- 아릴옥시-3- 알킬아미노-2-프로판올 니트레이트 에스테르, 이의 용도 및 상응하는 약제학적 조성물 | |
KR900001675A (ko) | 기관지확장 작용을 갖는 화합물 | |
KR870006054A (ko) | 치료 시스템의 제조방법 | |
DE60127839D1 (de) | Pflaster mit 4-biphenylessigsäure | |
KR910018024A (ko) | 경피흡수성 에페리손 또는 톨페리손 제제 | |
KR890001557A (ko) | 약학적 조성물 | |
KR870008834A (ko) | 아실-보효소 a:클레스테롤 아실 전이 효소의 억제제로서의 올레인산, 리놀산 또는 리놀렌산의 치환 아닐리드 | |
KR20070059758A (ko) | 비스테로이드성 항염증제와 국소마취제를 포함하는 경피투여 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20101208 Year of fee payment: 13 |
|
EXPY | Expiration of term |